Right ventricular dysfunction and risk of heart failure and mortality after myocardial infarction
Leonardo A. M. Zornoff, MD, PhD*,
Hicham Skali, MD*,
Marc A. Pfeffer, MD, PhD, FACC*,
Martin St. John Sutton, MD, FACC ,
Jean L. Rouleau, MD, FACC ,
Gervasio A. Lamas, MD, FACC ,
Ted Plappert, CVT ,
Jacques R. Rouleau, MD||,
Lemuel A. Moyé, MD, PhD¶,
Sandra J. Lewis, MDFACC#,
Eugene Braunwald, MD, FACC*,
Scott D. Solomon, MD, FACC*,* SAVE Investigators
* Cardiovascular Division, Brigham and Womens Hospital, Harvard Medical School, Boston, Massachusetts, USA
Cardiovascular Division, University of Pennsylvania, Philadelphia, Pennsylvania, USA
Cardiovascular Division, University Health Network and Mt. Sinai Hospital, Toronto, Ontario, Canada
Cardiovascular Division, Mt. Sinai Medical Center, Miami Beach, Florida, USA
|| Laval Hospital, Laval University, Sainte-Foy, Quebec, Canada
¶ School of Public Health, University of Texas, Houston, Texas, USA
# Portland Cardiovascular Institute, Portland, Oregon, USA

View larger version (11K):
[in a new window]
|
Figure 1 Cumulative percent survival of patients with and those without right ventricular (RV) dysfunction (fractional area change <32.2% or >32.2%). HR = hazard ratio.
|
|
|